BlackRock, Inc. 13D and 13G filings for iTeos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-23 8:57 pm Sale | 2025-03-31 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 2,179,420 5.700% | -1,703,129 (-43.87%) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 3,882,549 10.600% | 0 (Unchanged) | Filing |
| 2024-10-21 4:11 pm Sale | 2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 3,882,549 10.600% | -379,196 (-8.90%) | Filing |
| 2024-01-23 4:13 pm Sale | 2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 4,261,745 11.900% | -217,676 (-4.86%) | Filing |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 4,479,421 12.600% | 0 (Unchanged) | Filing |
| 2023-01-20 5:17 pm Purchase | 2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 4,479,421 12.600% | 758,184 (+20.37%) | Filing |
| 2022-07-08 4:56 pm Purchase | 2022-06-30 | 13G | iTeos Therapeutics, Inc. ITOS | BlackRock Inc. BLK | 3,721,237 10.500% | 3,721,237 (New Position) | Filing |